Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Expert Review of Anticancer Therapy|October 18, 2011
Where now for anti-EGF receptor therapies in colorectal cancer?Paul H S Shaw, Richard A Adams
Journal of Translational Medicine|July 8, 2015
Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancerRyan A Hutchinson, Richard A Adams, Darragh G McArt, et al.
Oncotarget|September 8, 2016
Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancerAnika Maria Weber, Neele Drobnitzky, Aoife Maire Devery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
A Road Map for Designing Phase I Clinical Trials of Radiotherapy-Novel Agent CombinationsSarah R Brown, Samantha Hinsley, Emma Hall, et al.
Cancer Treatment Reviews|November 29, 2011
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysisClaire L Vale, Jayne F Tierney, David Fisher, et al.
British Journal of Clinical Pharmacology|May 22, 2026
Cost-effectiveness of DPYD genotyping prior to fluoropyrimidine-based treatment for colorectal cancer in WalesCatrin O Plumpton, Sian M Morgan, Richard A Adams, et al.
Future Oncology (London, England)|July 28, 2020
Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progressionTheodora Germetaki, Camille Nicholls, Richard A Adams, et al.
JCO Precision Oncology|February 9, 2022
Role for Nucleotide Excision Repair Gene Variants in Oxaliplatin-Induced Peripheral NeuropathyHannah West, Michelle Coffey, Michael J Wagner, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2018
Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapyAyman Madi, David Fisher, Timothy S Maughan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximabChristopher G Smith, David Fisher, Bart Claes, et al.
Pageof 3